Vanguard Group Inc Frequency Therapeutics, Inc. Transaction History

Vanguard Group Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.35 - $0.72 $8,080 - $16,622	-23,087 Reduced 1.34%	1,704,479 $630,000
Q1 2023 May 15, 2023	BUY	$0.44 - $5.47 $1,936 - $24,068	4,400 Added 0.26%	1,727,566 $863,000
Q4 2022 Feb 10, 2023	SELL	$1.88 - $3.85 $96,477 - $197,574	-51,318 Reduced 2.89%	1,723,166 $6.63 Million
Q2 2022 Aug 12, 2022	BUY	$1.03 - $2.03 $544,075 - $1.07 Million	528,229 Added 42.39%	1,774,484 $2.66 Million
Q1 2022 May 13, 2022	SELL	$1.7 - $5.72 $358,640 - $1.21 Million	-210,965 Reduced 14.48%	1,246,255 $2.64 Million
Q4 2021 Feb 14, 2022	BUY	$4.95 - $7.11 $97,351 - $139,832	19,667 Added 1.37%	1,457,220 $7.48 Million
Q3 2021 Nov 12, 2021	BUY	$6.96 - $9.25 $62,702 - $83,333	9,009 Added 0.63%	1,437,553 $10.1 Million
Q2 2021 Aug 13, 2021	BUY	$8.05 - $11.61 $11.5 Million - $16.6 Million	1,428,544 New	1,428,544 $14.2 Million

Ticker FREQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,262,000
Description
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.